About this trial
Inadequate medication adherence (MA) in chronic conditions, including cardiovascular prevention, represents an important risk factor. The use of new IT technologies in this setting is supposed to be useful to improve patients' adherence, but currently available solutions have significant limitations, including lack of personalization and reliance on expensive ad hoc systems.
This interdisciplinary project aims to verify the hypothesis that in patients on chronic antihypertensive treatment MA can be improved through the implementation of a novel digital health solution for MA monitoring and support, based on inexpensive and user-friendly, commercially available technology (voice assistant), connected with web interface for the physician. The intervention will be personalized based on the creation of Personas, intended as multidisciplinary-based representations of different user types. This approach will be tested in a randomized clinical trial.
Eligibility criteria
Qualifiers
Adult (>18 years old) patients
History of essential hypertension
Treatment with at least one antihypertensive drug for which dedicated plasma essay is available
wireless internet connection available at patients' home
Disqualifiers
insufficient technological literacy to manage vocal assistant
dementia or significant psychiatric disorders
conditions significantly limiting vocal communication (deafness, significant speech disorders, poor knowledge of Italian language)
pregnancy or breastfeeding
Trial design
Treatments tested in this trial
- adherence support system based on a vocal assistant
Treatment groups
Locations
1Sponsors and collaborators
Istituto Auxologico Italiano
Lead sponsor
Istituti Clinici Scientifici Maugeri SpA
Collaborator
Politecnico di Milano
Collaborator